The city of Gilbert, Arizona, currently has 7 active clinical trials seeking participants for Arthritis research studies.
A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
Recruiting
The purpose of this study is to evaluate the efficacy and safety of deucravacitinib versus placebo in participants with active psoriatic arthritis who are naïve to biologic disease-modifying anti-rheumatic drugs. The long term extension period will provide additional long-term efficacy and safety information.
Gender:
All
Ages:
18 years and above
Trial Updated:
04/19/2024
Locations: Arizona Arthritis and Rheumatology Associates, Gilbert, Arizona
Conditions: Psoriatic Arthritis
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Recruiting
This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis (RA).
Gender:
All
Ages:
18 years and above
Trial Updated:
04/05/2024
Locations: Arizona Arthritis & Rheumatology Associates, P. C., Gilbert, Arizona
Conditions: Rheumatoid Arthritis
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
Recruiting
An open label phase 3 study
Gender:
All
Ages:
18 years and above
Trial Updated:
04/03/2024
Locations: Sunpharma site no 80, Gilbert, Arizona
Conditions: Psoriatic Arthritis
Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
Recruiting
This is a multicenter Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of tildrakizumab in Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
Gender:
All
Ages:
18 years and above
Trial Updated:
04/02/2024
Locations: Sunpharma Site no 29, Gilbert, Arizona
Conditions: Active Psoriatic Arthritis
INFINITY™ With ADAPTIS™ Technology Study
Recruiting
INFINITY™ with ADAPTIS™ Technology Total Ankle Replacement Follow-up (ITAR2) - Prospective, multi-site, multi-year post-market clinical follow-up study Study Group Primary/Unilateral and/or bilateral Total Ankle Arthroplasty subjects implanted with INFINITY™ Total Ankle System Number of Subjects 200 patients with up to 13 sites
Gender:
All
Ages:
22 years and above
Trial Updated:
02/16/2024
Locations: OrthoArizona Foot and Ankle Institute, Gilbert, Arizona
Conditions: Arthritis, Rheumatoid
FX Shoulder Solutions Retrospective / Prospective Clinical Study
Recruiting
Subjects implanted with the shoulder replacement medical devices manufactured by FX Shoulder Solutions and distributed by FX Shoulder Solutions.
Gender:
All
Ages:
All
Trial Updated:
10/10/2023
Locations: OrthoArizona, Gilbert, Arizona
Conditions: Rotator Cuff Syndrome of Shoulder and Allied Disorders, Osteoarthritis Shoulder, Fracture, Shoulder
FX Shoulder Prospective Clinical Study
Recruiting
Prospective Multi-Center Registry on study subjects with implanted devices marketed and legally commercialized in the USA by FX Shoulder Solutions.
Gender:
All
Ages:
All
Trial Updated:
10/05/2023
Locations: OrthoArizona, Gilbert, Arizona
Conditions: Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders, Fracture, Shoulder